| Size | Price | |
|---|---|---|
| Other Sizes |
Purity: ≥98%
| ln Vitro |
The study focused on the microscopy method of the enzyme-linked immunosorbent assay (ELISA), which uses ABTS as the substrate for the HRP conjugate. Four substrates were compared: 5-aminosalicylic acid (5AS), catecholamine (OPD), o-amine (OT), and ABTS. The results showed that ABTS was the most sensitive and efficient substrate for HRP. Blue-green appears to be the most stable and visually appealing [1]. For blocking and characterization, ABTS is a common peroxidase-positive transformant that is grown on a large scale (XL) for one hour under conditions that yield active protein in the culture supernatant. Once the activity against the substrate ABTS reached 55,000 U/L after 160 incubation, the peroxidase-containing supernatant was gathered. When the H2O2 concentration exceeded 0.125 mM, the peroxidase activity dramatically dropped using ABTS as the substrate, suggesting that H2O2 was inhibiting the enzyme. The maximum reaction rate is roughly between 31.2 and 125 μM, depending on the substrate that is tested [2].
|
|---|---|
| References |
|
| Molecular Formula |
C18H16N4O6S4.2(NH4)
|
|---|---|
| Molecular Weight |
548.68
|
| Exact Mass |
548.064
|
| CAS # |
30931-67-0
|
| Related CAS # |
28752-68-3 (Parent)
|
| PubChem CID |
9570474
|
| Appearance |
Light green to green solid powder
|
| Boiling Point |
881.2ºC at 760mmHg
|
| Flash Point |
486.7ºC
|
| LogP |
5.478
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
10
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
34
|
| Complexity |
883
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
ZTOJFFHGPLIVKC-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C18H18N4O6S4/c1-3-21-13-7-5-11(31(23,24)25)9-15(13)29-17(21)19-20-18-22(4-2)14-8-6-12(32(26,27)28)10-16(14)30-18/h5-10H,3-4H2,1-2H3,(H,23,24,25)(H,26,27,28)
|
| Chemical Name |
3-ethyl-2-[(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ≥ 50 mg/mL (~91.13 mM)
DMSO : ~20.83 mg/mL (~37.96 mM) |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (3.79 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (3.79 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.08 mg/mL (3.79 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. Solubility in Formulation 4: 50 mg/mL (91.13 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.8226 mL | 9.1128 mL | 18.2256 mL | |
| 5 mM | 0.3645 mL | 1.8226 mL | 3.6451 mL | |
| 10 mM | 0.1823 mL | 0.9113 mL | 1.8226 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
COA